Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It

The introduction of trastuzumab therapy markedly improved the poor prognosis associated with HER2-amplified breast cancers. Despite this, the presence of primary and acquired resistance to trastuzumab treatment remains a significant common challenge. The identification of resistance mechanisms and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luque-Cabal, María, García-Teijido, Paula, Fernández-Pérez, Yolanda, Sánchez-Lorenzo, Luisa, Palacio-Vázquez, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811269/
https://www.ncbi.nlm.nih.gov/pubmed/27042153
http://dx.doi.org/10.4137/CMO.S34537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811269/
https://www.ncbi.nlm.nih.gov/pubmed/27042153
http://dx.doi.org/10.4137/CMO.S34537

Ejemplares similares